title: In reply.
authors.affiliation: Department of Ophthalmology, University of California, San Francisco.
authors.forename: Noelle L
authors.initials: NL
authors.lastname: Pruzan
authors.affiliation: Department of Ophthalmology, University of California, San Francisco2Francis I. Proctor Foundation, University of California, San Francisco.
authors.forename: Jeremy D
authors.initials: JD
authors.lastname: Keenan
authors.affiliation: Department of Ophthalmology, University of California, San Francisco2Francis I. Proctor Foundation, University of California, San Francisco3Department of Ophthalmology, San Francisco General Hospital, San Francisco, California4Department of Ophthalmology.
authors.forename: Bennie H
authors.initials: BH
authors.lastname: Jeng
mesh_terms: D000935:Antifungal Agents / Q000494:pharmacology*; D002177:Candidiasis / Q000517:prevention & control*; D002809:Chondroitin Sulfates / Q000494:pharmacology*; D003315:Cornea; D003911:Dextrans / Q000494:pharmacology*; D004340:Drug Contamination / Q000517:prevention & control*; D005839:Gentamicins / Q000494:pharmacology*; D006801:Humans; D019188:Organ Preservation Solutions / Q000494:pharmacology*
chemical_list: D000935:Antifungal Agents; D003911:Dextrans; D005839:Gentamicins; D019188:Organ Preservation Solutions; D002809:Chondroitin Sulfates